Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Amylyx Pharmaceuticals, Inc. Common Stock | AMLX

AI Analysis of Amylyx Pharmaceuticals, Inc. Common Stock

Amylyx Pharmaceuticals is down a bit on the day, funds flowing out kept the price down -1.46% since yesterday.

Currently AMLX isn't at a clear support/resistance line that seems tradable. Momentum wise Amylyx Pharmaceuticals, has been oscillating up and down but hasn't shown much directional energy that would be predictive to the near future. AMLX may hit some resistance around the 13.9 level, more sellers may enter the market here and push price back down. But it's definitely not guaranteed.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-